Avalo Therapeutics (AVTX) Stock Chart & Stock Price History → Breaking - The US Gov. Seized CITGO (From Augury Research) (Ad) Free AVTX Stock Alerts $10.71 -0.28 (-2.55%) (As of 10:48 AM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Avalo Therapeutics Stock Price Performance5 Day Performance-5.95%1 Month Performance-17.06%3 Month Performance+109.73%6 Month Performance-24.44%Year-To-Date Performance+20.77%1 Year Performance-98.82% Receive AVTX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Avalo Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Augury ResearchBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is currently auctioning off CITGO (the winning bid will be announced on July 22nd).Get all the details here. AVTX Stock Chart for Friday, June, 7, 2024 AVTX Chart by TradingView Avalo Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/06/2024$11.01$10.99-0.18%$11.00$10.5017,853 shs$11.32 million06/05/2024$11.00$11.01+0.09%$11.57$10.6610,675 shs$11.38 million06/04/2024$11.45$11.00-3.93%$11.45$10.559,966 shs$11.33 million06/03/2024$11.69$11.45-2.01%$11.91$11.2315,410 shs$11.79 million05/31/2024$11.75$11.69-0.55%$11.94$11.4212,695 shs$12.04 million05/30/2024$12.05$11.75-2.49%$12.70$11.628,488 shs$12.10 million Get the Latest News and Ratings for AVTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Avalo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/29/2024$11.51$12.05+4.69%$12.90$11.6214,593 shs$12.41 million05/28/2024$13.10$11.51-12.14%$13.07$11.5116,106 shs$11.86 million05/27/2024$13.10$13.10$13.23$10.9844,800 shs$13.49 million05/24/2024$11.15$13.10+17.49%$13.23$10.9844,731 shs$13.49 million05/23/2024$10.79$11.15+3.34%$11.30$10.4126,020 shs$11.48 million05/22/2024$10.92$10.79-1.19%$11.09$10.269,770 shs$11.11 million05/21/2024$11.10$10.92-1.62%$11.20$10.5415,365 shs$11.25 million05/20/2024$9.59$11.10+15.75%$11.48$9.3258,841 shs$11.43 million05/17/2024$9.64$9.59-0.52%$10.07$8.9264,293 shs$9.92 million05/16/2024$10.39$9.64-7.22%$10.37$9.6324,563 shs$9.93 million05/15/2024$10.60$10.39-1.98%$10.93$10.0952,632 shs$10.70 million05/14/2024$10.82$10.60-2.03%$10.66$9.5853,056 shs$10.92 million05/13/2024$10.85$10.82-0.28%$11.20$10.6354,481 shs$11.15 million05/10/2024$11.49$10.85-5.57%$11.59$10.3557,346 shs$11.18 million05/09/2024$11.73$11.49-2.05%$12.63$11.4940,130 shs$11.84 million05/08/2024$13.25$11.73-11.47%$13.20$11.25147,947 shs$12.08 million05/07/2024$13.51$13.25-1.92%$13.76$13.1431,322 shs$13.65 million05/06/2024$14.36$13.51-5.92%$14.99$13.2734,733 shs$13.92 million05/03/2024$15.39$14.36-6.69%$16.00$13.1591,686 shs$14.79 million05/02/2024$16.01$15.39-3.87%$17.42$15.3953,627 shs$15.85 million05/01/2024$17.12$16.01-6.48%$17.10$14.7063,441 shs$16.49 million04/30/2024$16.88$17.12+1.42%$17.15$16.0139,078 shs$17.63 million04/29/2024$15.94$16.88+5.90%$17.49$15.6881,778 shs$17.39 million04/26/2024$14.98$15.94+6.41%$16.23$14.6978,196 shs$16.42 million04/25/2024$14.20$14.98+5.49%$16.32$13.65160,863 shs$15.43 million04/24/2024$13.00$14.20+9.23%$14.25$12.8036,845 shs$14.63 million04/23/2024$12.21$13.00+6.47%$13.74$12.3373,223 shs$13.39 million04/22/2024$11.63$12.21+4.99%$13.37$11.4683,438 shs$12.58 million04/19/2024$12.01$11.63-3.16%$13.02$11.5068,159 shs$11.98 million04/18/2024$13.62$12.01-11.82%$13.76$12.00107,236 shs$12.37 million04/17/2024$15.94$13.62-14.55%$15.93$13.52131,479 shs$14.03 million04/16/2024$15.24$15.94+4.59%$18.79$15.94220,529 shs$16.42 million04/15/2024$14.90$15.24+2.28%$15.69$14.5491,326 shs$15.70 million04/12/2024$15.75$14.90-5.40%$16.22$14.70127,024 shs$15.35 millionBreaking - The US Gov. Seized CITGO (Ad)Do you want an investment that can double or triple your money in the next three months? The US Court is currently auctioning off CITGO (the winning bid will be announced on July 22nd).Get all the details here.04/11/2024$15.06$15.75+4.58%$16.39$14.76128,830 shs$16.22 million04/10/2024$14.48$15.06+4.01%$15.62$13.79146,454 shs$15.51 million04/09/2024$14.19$14.48+2.04%$14.90$11.10354,786 shs$14.91 million04/08/2024$16.40$14.19-13.48%$17.20$14.16262,380 shs$14.67 million04/05/2024$16.30$16.40+0.61%$18.30$16.01279,181 shs$1.48 million04/04/2024$16.31$16.30-0.06%$20.85$16.30616,829 shs$1.39 million04/03/2024$15.16$16.31+7.59%$19.30$14.25448,728 shs$1.47 million04/02/2024$17.90$15.16-15.31%$17.33$14.50569,278 shs$1.36 million04/01/2024$21.75$17.90-17.70%$22.47$16.051.98 million shs$1.61 million03/29/2024$21.75$21.75$34.46$16.6531.53 million shs$1.85 million03/28/2024$4.75$21.75+357.89%$34.46$16.6531.83 million shs$1.96 million03/27/2024$4.76$4.75-0.21%$4.86$4.602.94 million shs$428,000.0003/26/2024$4.74$4.76+0.42%$4.89$4.629,560 shs$428,000.0003/25/2024$4.88$4.74-2.87%$4.93$4.6311,634 shs$427,000.0003/22/2024$4.60$4.88+6.09%$4.97$4.6736,144 shs$439,000.0003/21/2024$4.47$4.60+2.91%$4.84$4.4315,531 shs$414,000.0003/20/2024$4.35$4.47+2.76%$4.58$4.3630,030 shs$402,000.0003/19/2024$4.44$4.35-2.03%$4.56$4.359,877 shs$370,000.0003/18/2024$4.37$4.44+1.60%$4.73$4.3718,411 shs$400,000.0003/15/2024$5.00$4.37-12.60%$5.07$4.3728,859 shs$393,000.0003/14/2024$5.52$5.00-9.42%$5.72$5.0033,352 shs$425,000.0003/13/2024$5.45$5.52+1.28%$5.66$5.3535,773 shs$497,000.0003/12/2024$5.61$5.45-2.85%$5.67$5.2139,300 shs$490,000.0003/11/2024$5.88$5.61-4.59%$6.18$5.5552,601 shs$505,000.0003/08/2024$5.24$5.80+10.69%$6.17$5.3289,760 shs$522,000.0003/07/2024$5.15$5.24+1.75%$5.32$4.8642,605 shs$472,000.0003/06/2024$4.50$5.15+14.44%$5.24$4.49100,158 shs$464,000.00 Related Companies: Vincerx Pharma Stock Chart GlycoMimetics Stock Chart OncoCyte Stock Chart Sol-Gel Technologies Stock Chart Gain Therapeutics Stock Chart Kronos Bio Stock Chart Aadi Bioscience Stock Chart Daré Bioscience Stock Chart Ocuphire Pharma Stock Chart Reviva Pharmaceuticals Stock Chart Receive AVTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Avalo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AVTX) was last updated on 6/7/2024 by MarketBeat.com Staff From Our PartnersCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the ...Crypto 101 Media | SponsoredElon Musk’s Final Masterpiece: “X-9840”The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Ju...Paradigm Press | SponsoredAlert: Your Bank is Dying – Act Now or Lose Everything!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put...Priority Gold | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredHe Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a v...Crypto Swap Profits | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avalo Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avalo Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.